Metastatic prostate cancer recurrence within a percutaneous computed tomography guided needle biopsy tract: A rare case report

Abstract Background Metastatic prostate cancer tumor seeding within a percutaneous biopsy tract is rare. While reports of tumor seeding following perineal and transrectal prostate biopsies exist, no cases of prostate cancer tumor seeding along a metastatic percutaneous bone biopsy tract detected by prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) have been reported. Case Presentation We describe a rare case of intramuscular and subcutaneous prostate cancer recurrence along and adjacent to the site of a previous percutaneous metastatic rib biopsy tract. The role of PSMA PET/CT in the early detection of such cases is highlighted. In this case, PSMA PET played a crucial role in achieving both early diagnosis and early targeted management, optimizing the oncological outcome for the patient. Conclusion We hope to increase awareness of this rare presentation and emphasize the need for consensus on management approaches when encountering similar cases of prostate cancer tumor seeding in the future.

Authors

Institutions

Publication Details

Journal
UroPrecision
Published
2026-03-08
DOI
https://doi.org/10.1002/uro2.70059
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metastatic prostate cancer recurrence within a percutaneous computed tomography guided needle biopsy tract: A rare case report

Michael Kreltszheim, Thomas Neerhut, Abigail Attwell‐Heap, Thomas McMaster
UroPrecision
Prostate Cancer Diagnosis and Treatment
article

Metastatic prostate cancer recurrence within a percutaneous computed tomography guided needle biopsy tract: A rare case report

Michael Kreltszheim, Thomas Neerhut, Abigail Attwell‐Heap, Thomas McMaster
article en

Abstract

Abstract Background Metastatic prostate cancer tumor seeding within a percutaneous biopsy tract is rare. While reports of tumor seeding following perineal and transrectal prostate biopsies exist, no cases of prostate cancer tumor seeding along a metastatic percutaneous bone biopsy tract detected by prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) have been reported. Case Presentation We describe a rare case of intramuscular and subcutaneous prostate cancer recurrence along and adjacent to the site of a previous percutaneous metastatic rib biopsy tract. The role of PSMA PET/CT in the early detection of such cases is highlighted. In this case, PSMA PET played a crucial role in achieving both early diagnosis and early targeted management, optimizing the oncological outcome for the patient. Conclusion We hope to increase awareness of this rare presentation and emphasize the need for consensus on management approaches when encountering similar cases of prostate cancer tumor seeding in the future.

UroPrecision
Sunshine Coast University Hospital (AU)
Good health and well-being
Openalex Percentile: Top 29%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metastatic prostate cancer recurrence within a percutaneous computed tomography guided needle biopsy tract: A rare case report — Michael Kreltszheim, Thomas Neerhut, et al. · UroPrecision (2026) | TGRS Research Map | TGRS